{
  "url": "https://openlegislation.uk/general-pharmaceutical-council-statutory-committees-and-their-advisers-rules-order-of-council-2010/schedule/rule-13",
  "json_url": "https://openlegislation.uk/general-pharmaceutical-council-statutory-committees-and-their-advisers-rules-order-of-council-2010/schedule/rule-13.json",
  "legislation": "uksi/2010/1616",
  "legislation_title": "The General Pharmaceutical Council (Statutory Committees and their Advisers Rules) Order of Council 2010",
  "legislation_url": "https://openlegislation.uk/general-pharmaceutical-council-statutory-committees-and-their-advisers-rules-order-of-council-2010",
  "path": "schedule/rule/13",
  "kind": "rule",
  "number": "13",
  "heading": "Reserve list",
  "text": "(1) The Appointments Committee must maintain a reserve list of persons who are eligible to serve as a member of one or more statutory committees.\n(1A) In relation to any person whose name appears on the reserve list, the Appointments Committee must specify—\n(a) the statutory committee or statutory committees to which appointment may be appropriate;\n(b) whether any appointment would be as a registrant member or as a lay member;\n(c) whether appointment as a chair or deputy chair of the Investigating Committee may be appropriate;\n(d) whether appointment as a deputy chair of the Fitness to Practise Committee may be appropriate; and\n(e) whether appointment as a chair or deputy chair of the Appeals Committee may be appropriate.\n(1B) In relation to any person whose name appears on the reserve list, where—\n(a) both the Fitness to Practise Committee and the Appeals Committee are specified as statutory committees to which the person’s appointment may be appropriate; and\n(b) the person is appointed to one of those committees,\nthe person’s name may be retained on the reserve list for the purpose of appointment to the other committee.\n(2) Persons may only be retained on the reserve list for a period of 3 consecutive years, after which time their suitability for continued inclusion in that list is to be reconsidered by the Appointments Committee.\n(3) Persons on the reserve list may be appointed to fill a vacancy that arises on a statutory committee only if—\n(a) the matters specified in the reserve list under paragraph (1A) in respect of that person show that the person is suitable for the vacancy; and\n(b) the Appointments Committee considers that it would be appropriate to make the appointment.\n(4) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .\n(5) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .\n(6) Persons on the reserve list may be invited to attend training provided or arranged by the Council (which may be training provided by another body) to maintain their suitability for continued inclusion on the reserve list.\n(7) Where a member of a statutory committee other than the chair is unable to sit to consider a case for any reason, the chair of the committee may co-opt a person whose name appears on the reserve list to serve as a member of the committee (including as a deputy chair) for that particular case if—\n(a) that committee is specified as a statutory committee to which the person’s appointment may be appropriate; and\n(b) the chair considers that it would be appropriate for the person to serve as a member of the committee.\n(8) A person may not be co-opted under paragraph (7) to be at the same time—\n(a) a member of the Investigating Committee; and\n(b) a member of another statutory committee.",
  "extent": "E+W+S",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Sch. rule 13(1) substituted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 11(2)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Sch. rule 13(1A)(1B) inserted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 11(3)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Sch. rule 13(3) substituted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 11(4)"
    },
    {
      "type": "F",
      "label": "F4",
      "text": "Sch. rule 13(4)(5) omitted (5.2.2013) by virtue of The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 11(5)"
    },
    {
      "type": "F",
      "label": "F5",
      "text": "Sch. rule 13(7) substituted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 11(6)"
    },
    {
      "type": "F",
      "label": "F6",
      "text": "Sch. rule 13(8) inserted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 11(7)"
    },
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. rule 13 in force at 27.9.2010, see Sch. rule 1"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2010/1616/schedule/rule/13",
    "retrieved_at": "2026-11-06T03:38:08.493928+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}